BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34298450)

  • 1. Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis.
    Abu-Zaid A; Alomar O; Baradwan S; Abuzaid M; Alshahrani MS; Allam HS; Alqarni SMS; Nazer A; Salem H; Al-Badawi IA
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():88-96. PubMed ID: 34298450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis.
    Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Leukocytosis as a Prognostic Marker in Endometrioid-Type Endometrial Cancer: A Single-Center Experience from Saudi Arabia.
    Salem H; Abu-Zaid A; Aloman O; Abuzaid M; Alsabban M; Elhassan T; Salem A; Alyamani Y; Al-Badawi IA
    Gulf J Oncolog; 2020 Jan; 1(32):51-58. PubMed ID: 32342919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of preoperative leukocytosis in endometrial carcinoma.
    Worley MJ; Nitschmann CC; Shoni M; Vitonis AF; Rauh-Hain JA; Feltmate CM
    Gynecol Oncol; 2012 Jun; 125(3):561-5. PubMed ID: 22465698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma.
    Worley MJ; Nitschmann CC; Shoni M; Rauh-Hain JA; Williams KA; Feltmate CM
    Int J Gynecol Cancer; 2013 Feb; 23(2):312-7. PubMed ID: 23358179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of human epididymis protein 4 expression in patients with endometrial cancer: A systematic review and meta-analysis.
    Han LN; Han YW; Yan P
    J Obstet Gynaecol Res; 2022 Sep; 48(9):2255-2269. PubMed ID: 35844088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
    Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
    Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
    Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 overexpression as a prognostic indicator in endometrial carcinoma.
    Ozalp S; Yalcin OT; Tanir HM; Kabukcuoglu S; Erol G
    Eur J Gynaecol Oncol; 2003; 24(3-4):275-8. PubMed ID: 12807239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
    López-González E; Rodriguez-Jiménez A; Gómez-Salgado J; Daza-Manzano C; Rojas-Luna JA; Alvarez RM
    Int J Gynaecol Obstet; 2023 Dec; 163(3):840-846. PubMed ID: 37350418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 17. Incorporation of pretreatment leukocytosis and thrombocytosis into the FIGO staging system for prognosis in surgically treated endometrial cancer.
    Yokoi E; Mabuchi S; Komura N; Shimura K; Matsumoto Y; Kimura T
    Int J Gynaecol Obstet; 2020 Nov; 151(2):272-278. PubMed ID: 32712993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer.
    Todo Y; Kato H; Okamoto K; Minobe S; Yamashiro K; Sakuragi N
    J Gynecol Oncol; 2016 Jan; 27(1):e1. PubMed ID: 25925293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
    Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.
    Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM
    Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.